Cross-sectional study shows changes in ADHD medication prescription rates in Ontario, indicating evolving treatment approaches.
This cross-sectional study describes changes in prescription rates for attention-deficit/hyperactivity (ADHD) disorder medication in Ontario from 2015 to 2023.
No takes yet. Share an insight, caveat, or question.
Myran et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: